Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004110850 | SCV003590014 | uncertain significance | not specified | 2022-02-11 | criteria provided, single submitter | clinical testing | The c.550G>A (p.V184I) alteration is located in exon 5 (coding exon 5) of the BHLHE41 gene. This alteration results from a G to A substitution at nucleotide position 550, causing the valine (V) at amino acid position 184 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003953987 | SCV004777338 | likely benign | BHLHE41-related disorder | 2023-03-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |